ImmunoGenesis
ImmunoGenesis valuation and funding history | Last updated: December 4, 2025 | 1 funding rounds
Current Valuation
N/A
As of December 4, 2025
Total Funding Raised
$67.2M
Across 1 round
Last Round
Grant
$10.8M
Last Funding
Dec 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| N/A | Unknown | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
ImmunoGenesis is currently valued at N/A as of December 4, 2025. The company has raised a total of $67.2M in funding across 1 funding round.
What is ImmunoGenesis Worth in 2026?
ImmunoGenesis is a leading private company in the technology sector. Track ImmunoGenesis's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How ImmunoGenesis Valuation is Determined
Private company valuations like ImmunoGenesis's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.